SOURCE: BDI Pharma, Inc.

BDI Pharma, Inc.

March 10, 2010 11:32 ET

Biotech Distributor BDI Pharma Celebrates 15th Anniversary in Conjunction With Successful Rebranding

COLUMBIA, SC--(Marketwire - March 10, 2010) -  BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, recognized two distinct milestones during the first quarter of 2010 -- 15 years in business and the first anniversary of the organization's re-branding. BDI was founded on January 27, 1995 as Blood Diagnostics, Inc. focusing primarily upon products that comprise the plasma derivative and recombinant pharmaceutical market. In the latter half of 2007, the process of significantly expanding the company's portfolio began. The success of this expansion ultimately resulted in the organization's re-branding to better reflect the breadth of the specialty biopharmaceuticals offered. On February 2, 2009, BDI Pharma, Inc. officially became the corporation's new name. To make the transformation complete, the organization began operations in its new corporate headquarters on that very same day.

Richard J. Gaton, Co-President of BDI Pharma, attributed consistent growth over the years to the service oriented focus of the company. "We are a solutions-based organization continually challenging ourselves to develop and implement programs to meet and exceed the varied and changing needs of both our customers and our trade partners, alike," stated Mr. Gaton. "The marketing platforms built by our team enabled us to successfully diversify BDI's portfolio without sacrificing the service driven model which has defined our company since its inception."

About BDI Pharma, Inc.

Serving the healthcare community since 1995, BDI Pharma, Inc. has built an outstanding reputation as an industry source for products and service. BDI Pharma's market focus is evident in its commitment to specialty biotherapeutics, chemotherapies, vaccines and plasma protein therapies, including Albumin, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, hyper-immunes, and injectables. As a manufacturer recognized Authorized Distributor of Record, BDI Pharma, Inc. services the entire country and is fully accredited and insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information on market availability is paramount to patient care, BDI Pharma, Inc. defines its customer-centric approach to serving the nation's healthcare community through innovative inventory management programs, unparalleled customer service, extensive product knowledge, unique promotional services, emergency availability and urgent need delivery. The company serves as a source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI Pharma, Inc.'s educational literature and Web site -- -- serve as open-access resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.

Contact Information

  • Contact:
    Brad Davis
    Director of Marketing
    Email Contact